Zhi-sheng Jiang
421001, PR China
Hengyang, Puerto Rico
Hengyang, Puerto Rico
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
SIRT3 sulfhydrylation by hydrogen sulphide: A novel approach to prevent ferroptosis and atrial fibrosis.
Journal: Nitric oxide : biology and chemistry
Published: January 17, 2025
SIRT3 sulfhydration using hydrogen sulfide inhibited angiotensin II-induced atrial fibrosis and vulnerability to atrial fibrillation via suppression of the TGF-β1/smad2/3 signalling pathway.
Journal: European journal of pharmacology
Published: October 25, 2023
TRIM65 Suppresses oxLDL-induced Endothelial Inflammation by Interaction with VCAM-1 in Atherogenesis.
Journal: Current medicinal chemistry
Published: December 27, 2022
TRIMs: Generalists Regulating the NLRP3 Inflammasome Signaling Pathway.
Journal: DNA and cell biology
Published: February 18, 2022
The emerging roles of extracellular vesicles in diabetes and diabetic complications.
Journal: Clinica chimica acta; international journal of clinical chemistry
Published: April 10, 2019
PCSK9: A new participant in lipophagy in regulating atherosclerosis?
Journal: Clinica chimica acta; international journal of clinical chemistry
Published: April 03, 2019
miR-23b-3p and miR-125b-5p downregulate apo(a) expression by targeting Ets1 in HepG2 cells.
Journal: Cell biology international
Published: September 13, 2017
Corrigendum to "Ox-Lp(a) transiently induces HUVEC autophagy via an ROS-dependent PAPR-1-LKB1-AMPK-mTOR pathway" [Atherosclerosis 243 (1) (2015) 223-235].
Journal: Atherosclerosis
Published: May 12, 2016
Ox-Lp(a) transiently induces HUVEC autophagy via an ROS-dependent PAPR-1-LKB1-AMPK-mTOR pathway.
Journal: Atherosclerosis
Published: June 04, 2014
H2S, a novel therapeutic target in renal-associated diseases?
Journal: Clinica chimica acta; international journal of clinical chemistry
Published: March 28, 2014
Showing 1-11 of 11
Last Updated: 09/26/2026